Home
Conditions
Respiratory Hypersensitivity

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,456 public trials 325 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)

NCT00076076

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: ALTANA Pharma Cities in Alabama, Alabama, United States

ALTANA Pharma Cities in Arizona, Arizona, United States

ALTANA Pharma Cities in Arkansas, Arkansas, United States

ALTANA Pharma Cities in California, California, United States

View all 41 locations

View Trial Details

Completed

Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)

NCT00163527

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: ALTANA Pharma Cities in Georgia, Georgia, United States

ALTANA Pharma Cities in Austria, Austria

ALTANA Pharma Cities in Croatia, Croatia

ALTANA Pharma Cities in the Czech Repulik, Czechia

View all 24 locations

View Trial Details

Completed

Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)

NCT00163319

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Altana Pharma/Nycomed Brussels, Belgium

Altana Pharma/Nycomed Brussels, Belgium

Altana Pharma/Nycomed Brussels, Belgium

Altana Pharma/Nycomed Halen, Belgium

View all 89 locations

View Trial Details

Completed

Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)

NCT00659503

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: Altana/Nycomed Kingston, Ontario, Canada

View Trial Details

Completed

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)

NCT00163410

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Altana Pharma/Nycomed Ahmedabad, India

Altana Pharma/Nycomed Bangalore, India

Altana Pharma/Nycomed Chandigarh, India

Altana Pharma/Nycomed Coimbatore, India

View all 16 locations

View Trial Details

Completed

To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)

NCT00658918

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +9 more
Locations: Altana/Nycomed Little Rock, Arkansas, United States

View Trial Details

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

NCT00163514

Conditions: Allergic Rhinitis, Hay Fever, Hypersensitivity, +11 more
Locations: Altana Pharma/Nycomed Oxford, Alabama, United States

Altana Pharma/Nycomed Huntington Beach, California, United States

Altana Pharma/Nycomed Mission Viejo, California, United States

Altana Pharma/Nycomed Newport Beach, California, United States

View all 74 locations

View Trial Details

Completed

Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

NCT00659048

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: Altana/Nycomed San Antonio, Texas, United States

View Trial Details

Completed

A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

NCT01245426

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Sofia, Bulgaria

GSK Investigational Site Hamburg, Free and Hanseatic City of Hamburg, Germany

GSK Investigational Site Frankfurt am Main, Hesse, Germany

GSK Investigational Site Hanover, Lower Saxony, Germany

View Trial Details

Completed

Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)

NCT00163371

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Altana Pharma/Nycomed Kolding, Denmark

View Trial Details

Respiratory Hypersensitivity

Respiratory Hypersensitivity trial results

Related conditions